Prediction of drug adverse events using deep learning in pharmaceutical discovery

被引:46
|
作者
Lee, Chun Yen [1 ]
Chen, Yi-Ping Phoebe [1 ]
机构
[1] La Trobe Univ, Dept Comp Sci & Informat Technol, Melbourne, Vic, Australia
关键词
deep learning; pharmacovigilance; adverse drug reactions; INTERACTION EXTRACTION; NEURAL-NETWORKS;
D O I
10.1093/bib/bbaa040
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Traditional machine learning methods used to detect the side effects of drugs pose significant challenges as feature engineering processes are labor-intensive, expert-dependent, time-consuming and cost-ineffective. Moreover, these methods only focus on detecting the association between drugs and their side effects or classifying drug-drug interaction. Motivated by technological advancements and the availability of big data, we provide a review on the detection and classification of side effects using deep learning approaches. It is shown that the effective integration of heterogeneous, multidimensional drug data sources, together with the innovative deployment of deep learning approaches, helps reduce or prevent the occurrence of adverse drug reactions (ADRs). Deep learning approaches can also be exploited to find replacements for drugs which have side effects or help to diversify the utilization of drugs through drug repurposing.
引用
下载
收藏
页码:1884 / 1901
页数:18
相关论文
共 50 条
  • [21] Deep learning for in vitro prediction of pharmaceutical formulations
    Yilong Yang
    Zhuyifan Ye
    Yan Su
    Qianqian Zhao
    Xiaoshan Li
    Defang Ouyang
    Acta Pharmaceutica Sinica B, 2019, 9 (01) : 177 - 185
  • [22] Adverse Drug Events: Database Construction and in Silico Prediction
    Cheng, Feixiong
    Li, Weihua
    Wang, Xichuan
    Zhou, Yadi
    Wu, Zengrui
    Shen, Jie
    Tang, Yun
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2013, 53 (04) : 744 - 752
  • [23] Exploiting complex medical data with interpretable deep learning for adverse drug event prediction
    Rebane, Jonathan
    Samsten, Isak
    Papapetrou, Panagiotis
    ARTIFICIAL INTELLIGENCE IN MEDICINE, 2020, 109
  • [24] LiSA: an assisted literature search pipeline for detecting serious adverse drug events with deep learning
    Martenot, Vincent
    Masdeu, Valentin
    Cupe, Jean
    Gehin, Faustine
    Blanchon, Margot
    Dauriat, Julien
    Horst, Alexander
    Renaudin, Michael
    Girard, Philippe
    Zucker, Jean-Daniel
    BMC MEDICAL INFORMATICS AND DECISION MAKING, 2022, 22 (01)
  • [25] LiSA: an assisted literature search pipeline for detecting serious adverse drug events with deep learning
    Vincent Martenot
    Valentin Masdeu
    Jean Cupe
    Faustine Gehin
    Margot Blanchon
    Julien Dauriat
    Alexander Horst
    Michael Renaudin
    Philippe Girard
    Jean-Daniel Zucker
    BMC Medical Informatics and Decision Making, 22
  • [26] Efficient prediction of drug-drug interaction using deep learning models
    Shukla, Prashant Kumar
    Shukla, Piyush Kumar
    Sharma, Poonam
    Rawat, Paresh
    Samar, Jashwant
    Moriwal, Rahul
    Kaur, Manjit
    IET SYSTEMS BIOLOGY, 2020, 14 (04) : 211 - 216
  • [27] Spectrum of deep learning algorithms in drug discovery
    Piroozmand, Firoozeh
    Mohammadipanah, Fatemeh
    Sajedi, Hedieh
    CHEMICAL BIOLOGY & DRUG DESIGN, 2020, 96 (03) : 886 - 901
  • [28] Recent Progress of Deep Learning in Drug Discovery
    Wang, Feng
    Diao, XiaoMin
    Chang, Shan
    Xu, Lei
    CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (17) : 2088 - 2096
  • [29] Deep Learning and Drug Discovery for Healthy Aging
    Wang, Peter
    Ho, Dean
    ACS CENTRAL SCIENCE, 2023, 9 (10) : 1860 - 1863
  • [30] Limits of Prediction for Machine Learning in Drug Discovery
    von Korff, Modest
    Sander, Thomas
    FRONTIERS IN PHARMACOLOGY, 2022, 13